{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T11:53:21Z","timestamp":1783598001610,"version":"3.55.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.coms.2021.11.008","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T01:11:55Z","timestamp":1649380315000},"page":"299-314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management of Head and Neck Mucosal Melanoma"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1750-3179","authenticated-orcid":false,"given":"Pablo","family":"Nenclares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.coms.2021.11.008_bib1","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.coms.2021.11.008_bib2","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1245\/s10434-011-1685-4","article-title":"Predictors of survival in mucosal melanoma of the head and neck","volume":"18","author":"Jethanamest","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0003-9969(96)00113-6","article-title":"The immunohistochemical identification of human oral mucosal melanocytes","volume":"42","author":"Barrett","year":"1997","journal-title":"Arch Oral Biol"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib4","first-page":"47","article-title":"Biophysiology of oral mucosal melanocytes","volume":"10","author":"Natesan","year":"2020","journal-title":"J\u00a0Health Sci Res"},{"issue":"6","key":"10.1016\/j.coms.2021.11.008_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1079-2104(98)90209-8","article-title":"Melanoma arising from the mucosal surfaces of the head and neck","volume":"86","author":"Gorsky","year":"1998","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib6","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1186\/s12885-018-4977-2","article-title":"Predominance of triple wild-type and IGF2R mutations in mucosal melanomas","volume":"18","author":"Iida","year":"2018","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib7","first-page":"9","article-title":"Malignant melanomas of the nasal cavity after occupational exposure to formaldehyde","volume":"48","author":"Holmstrom","year":"1991","journal-title":"Br J Ind Med"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1368-8375(99)00085-8","article-title":"Oral mucosal melanoma: epidemiology and pathobiology","volume":"36","author":"Hicks","year":"2000","journal-title":"Oral Oncol"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2273.1998.00099.x","article-title":"Mucosal melanoma of the head and neck","volume":"23","author":"Nandapalan","year":"1998","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"8","key":"10.1016\/j.coms.2021.11.008_bib10","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1373::AID-CNCR3>3.0.CO;2-G","article-title":"Malignant mucosal melanoma of the head and neck","volume":"80","author":"Manolidis","year":"1997","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-018-0782-4","article-title":"Mechanisms of receptor tyrosine kinase activation in cancer","volume":"17","author":"Du","year":"2018","journal-title":"Mol Cancer"},{"issue":"22","key":"10.1016\/j.coms.2021.11.008_bib12","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.coms.2021.11.008_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.18632\/oncoscience.51","article-title":"Resistance to c-Kit inhibitors in melanoma: insights for future therapies","volume":"1","author":"Carlino","year":"2014","journal-title":"Oncoscience"},{"issue":"8","key":"10.1016\/j.coms.2021.11.008_bib14","doi-asserted-by":"crossref","first-page":"e24064","DOI":"10.1371\/journal.pone.0024064","article-title":"C-KIT signaling depends on microphthalmia-associated transcription factor for effects on cell proliferation","volume":"6","author":"Phung","year":"2011","journal-title":"PLoS One"},{"issue":"7047","key":"10.1016\/j.coms.2021.11.008_bib15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"Garraway","year":"2005","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.coms.2021.11.008_bib16","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.coms.2021.11.008_bib17","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/sj.bjc.6604791","article-title":"Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas","volume":"99","author":"Satzger","year":"2008","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.coms.2021.11.008_bib18","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-10-2917","article-title":"KIT pathway alterations in mucosal melanomas of the vulva and other sites","volume":"17","author":"Omholt","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.coms.2021.11.008_bib19","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hed.23079","article-title":"Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases","volume":"35","author":"Turri-Zanoni","year":"2013","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00428-007-0524-2","article-title":"C-kit protein expression correlated with activating mutations in KIT gene in oral mucosal melanoma","volume":"452","author":"Rivera","year":"2008","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib21","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1038\/s41467-019-11107-x","article-title":"Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets","volume":"10","author":"Newell","year":"2019","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.coms.2021.11.008_bib22","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1600-0463.2007.apm_855.xml.x","article-title":"The genome and epigenome of malignant melanoma","volume":"115","author":"Dahl","year":"2007","journal-title":"APMIS"},{"issue":"7653","key":"10.1016\/j.coms.2021.11.008_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jmg.2003.016667","article-title":"Absence of BRAF mutations in UV-protected mucosal melanomas","volume":"41","author":"Edwards","year":"2004","journal-title":"J\u00a0Med Genet"},{"issue":"8","key":"10.1016\/j.coms.2021.11.008_bib25","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3390\/cancers11081133","article-title":"Atypical BRAF and NRAS mutations in mucosal melanoma","volume":"11","author":"Dumaz","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.coms.2021.11.008_bib26","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bjc.2017.125","article-title":"Mutation status among patients with sinonasal mucosal melanoma and its impact on survival","volume":"116","author":"Amit","year":"2017","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.coms.2021.11.008_bib27","first-page":"9786","article-title":"KIT, NRAS, BRAF and FMNL2 mutations in oral mucosal melanoma and a systematic review of the literature","volume":"15","author":"Chen","year":"2018","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13053-021-00178-x","article-title":"CDKN2A germline alterations and the relevance of genotype-phenotype associations in cancer predisposition","volume":"19","author":"Chan","year":"2021","journal-title":"Hered Cancer Clin Pract"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1445-2197.2005.03343.x","article-title":"Experience with mucosal melanoma of the nose and paranasal sinuses","volume":"75","author":"Bridger","year":"2005","journal-title":"ANZ J Surg"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0266-4356(94)90172-4","article-title":"Primary malignant melanoma of the oral cavity--its histological classification and treatment","volume":"32","author":"Umeda","year":"1994","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"7","key":"10.1016\/j.coms.2021.11.008_bib31","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/1097-0142(19950401)75:7<1568::AID-CNCR2820750704>3.0.CO;2-M","article-title":"Laryngeal mucosal malignant melanoma. A clinicopathologic, immunohistochemical, and ultrastructural study of four patients and a review of the literature","volume":"75","author":"Wenig","year":"1995","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.coms.2021.11.008_bib32","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/cncr.20201","article-title":"Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, stage I (lymph node-negative) tumors","volume":"100","author":"Prasad","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/DAD.0b013e3181a0d37c","article-title":"Primary oral mucosal melanoma: a series of 35 new cases from South America","volume":"31","author":"Louren\u00e7o","year":"2009","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.coms.2021.11.008_bib34","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/00000478-200106000-00010","article-title":"Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa","volume":"25","author":"Prasad","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.coms.2021.11.008_bib35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00000478-200305000-00004","article-title":"Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system","volume":"27","author":"Thompson","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib36","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/annonc\/mdw694","article-title":"The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients","volume":"28","author":"Lian","year":"2017","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib37","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1102\/1470-7330.2013.0055","article-title":"Metastatic mucosal melanoma: imaging patterns of metastasis and recurrence","volume":"13","author":"O'Regan","year":"2013","journal-title":"Cancer Imaging"},{"issue":"6","key":"10.1016\/j.coms.2021.11.008_bib38","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1007\/s00330-015-3992-9","article-title":"Metastatic patterns and metastatic sites in mucosal melanoma: a retrospective study","volume":"26","author":"Gr\u00f6zinger","year":"2016","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1016\/j.coms.2021.11.008_bib39","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/cncr.24976","article-title":"Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center","volume":"116","author":"Moreno","year":"2010","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.coms.2021.11.008_bib40","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.oraloncology.2008.01.014","article-title":"Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma","volume":"44","author":"McLean","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.coms.2021.11.008_bib41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.critrevonc.2017.01.019","article-title":"Mucosal melanoma of the head and neck","volume":"112","author":"Ascierto","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"10.1016\/j.coms.2021.11.008_bib42","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/hed.20878","article-title":"Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital","volume":"30","author":"Bachar","year":"2008","journal-title":"Head Neck"},{"issue":"12","key":"10.1016\/j.coms.2021.11.008_bib43","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1002\/lary.23625","article-title":"Mucosal melanoma of the head and neck: 32-year experience in a tertiary referral hospital","volume":"122","author":"Chan","year":"2012","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0975-5950.183856","article-title":"Primary malignant melanoma of oral cavity: a tertiary care center experience","volume":"6","author":"Kumar","year":"2015","journal-title":"Natl J Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.anl.2006.09.027","article-title":"Primary malignant melanoma of the larynx: a case report and literature review","volume":"34","author":"Terada","year":"2007","journal-title":"Auris Nasus Larynx"},{"issue":"6","key":"10.1016\/j.coms.2021.11.008_bib46","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/ajot.2000.18865","article-title":"Malignant melanoma of the sinonasal cavity: explanation of magnetic resonance signal intensities with histopathologic characteristics","volume":"21","author":"Kim","year":"2000","journal-title":"Am J Otolaryngol"},{"issue":"20","key":"10.1016\/j.coms.2021.11.008_bib47","first-page":"3687","article-title":"Characteristic findings of malignant melanoma in the sinonasal cavity on magnetic resonance imaging","volume":"125","author":"Xu","year":"2012","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1016\/j.coms.2021.11.008_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/1450-1147.207274","article-title":"Positron emission tomography in mucosal melanomas of head and neck: results from a South Asian Tertiary Cancer Care Center","volume":"16","author":"Agrawal","year":"2017","journal-title":"World J Nucl Med"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib49","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9610(70)80001-0","article-title":"Malignant melanoma of the skin of the head and neck. An analysis of 405 cases","volume":"120","author":"Ballantyne","year":"1970","journal-title":"Am J Surg"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib50","first-page":"e425","article-title":"Comparative study between two different staging systems (AJCC TNM VS BALLANTYNE'S) for mucosal melanomas of the Head & Neck","volume":"21","author":"Luna-Ortiz","year":"2016","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/alr.21831","article-title":"The presentation and outcomes of mucosal melanoma in 695 patients","volume":"7","author":"Konuthula","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib52","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1945892418822637","article-title":"Open versus endoscopic approach for sinonasal melanoma: a systematic review and meta-analysis","volume":"33","author":"Hur","year":"2019","journal-title":"Am J Rhinol Allergy"},{"issue":"5","key":"10.1016\/j.coms.2021.11.008_bib53","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-0037-1603960","article-title":"The utility of sentinel node biopsy for sinonasal melanoma","volume":"78","author":"Oldenburg","year":"2017","journal-title":"J\u00a0Neurol Surg B Skull Base"},{"issue":"5","key":"10.1016\/j.coms.2021.11.008_bib54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/01.cmr.0000222603.57932.b6","article-title":"Sentinel lymph node biopsy: a new perspective in head and neck mucosal melanoma?","volume":"16","author":"St\u00e1rek","year":"2006","journal-title":"Melanoma Res"},{"issue":"9","key":"10.1016\/j.coms.2021.11.008_bib55","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jcms.2019.06.012","article-title":"Primary head and neck mucosal melanoma: predictors of survival and a case series on sentinel node biopsy","volume":"47","author":"Prinzen","year":"2019","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"3","key":"10.1016\/j.coms.2021.11.008_bib56","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/cncr.31083","article-title":"Approaches to regional lymph node metastasis in patients with head and neck mucosal melanoma","volume":"124","author":"Amit","year":"2018","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.oraloncology.2014.01.008","article-title":"Neck dissection for oral mucosal melanoma: caution of nodular lesion","volume":"50","author":"Wu","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.coms.2021.11.008_bib58","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1186\/s12885-015-1750-7","article-title":"Evaluation of the prognostic impact of postoperative adjuvant radiotherapy on head and neck mucosal melanoma: a meta-analysis","volume":"15","author":"Li","year":"2015","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib59","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jcms.2015.02.011","article-title":"Postoperative adjuvant radiotherapy improves loco-regional recurrence of head and neck mucosal melanoma","volume":"43","author":"Wushou","year":"2015","journal-title":"J\u00a0Craniomaxillofac Surg"},{"issue":"12","key":"10.1016\/j.coms.2021.11.008_bib60","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1017\/S0022215118002189","article-title":"Surgery alone versus post-operative radiotherapy for sinonasal malignant melanoma: a meta-analysis","volume":"132","author":"Hu","year":"2018","journal-title":"J\u00a0Laryngol Otol"},{"key":"10.1016\/j.coms.2021.11.008_bib61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.oraloncology.2019.07.026","article-title":"Risk-based stratification in head and neck mucosal melanoma","volume":"97","author":"Moya-Plana","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.coms.2021.11.008_bib62","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.oraloncology.2019.03.017","article-title":"Clinically node-negative head and neck mucosal melanoma: an analysis of current treatment guidelines & outcomes","volume":"92","author":"Torabi","year":"2019","journal-title":"Oral Oncol"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib63","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/coa.13033","article-title":"Adjuvant radiotherapy in sinonasal mucosal melanoma: a retrospective analysis","volume":"43","author":"Caspers","year":"2018","journal-title":"Clin Otolaryngol"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib64","first-page":"124","article-title":"Primary mucosal melanoma of the nasal cavity and paranasal sinuses: 12 years of experience","volume":"36","author":"Huang","year":"2007","journal-title":"J\u00a0Otolaryngol"},{"issue":"5","key":"10.1016\/j.coms.2021.11.008_bib65","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/014556139907800511","article-title":"Head and neck mucosal melanoma: a 32-year review","volume":"78","author":"Loree","year":"1999","journal-title":"Ear Nose Throat J"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib66","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ijrobp.2003.11.013","article-title":"A\u00a0multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan","volume":"59","author":"Wada","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib67","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/hed.24979","article-title":"Local control in sinonasal malignant melanoma: comparing conventional to hypofractionated radiotherapy","volume":"40","author":"Lansu","year":"2018","journal-title":"Head Neck"},{"issue":"17","key":"10.1016\/j.coms.2021.11.008_bib68","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1002\/cam4.2614","article-title":"Carbon-ion radiotherapy combined with chemotherapy for head and neck mucosal melanoma: prospective observational study","volume":"8","author":"Takayasu","year":"2019","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib69","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1016\/j.ijrobp.2016.06.1474","article-title":"A\u00a0retrospective multi-institutional study of proton beam therapy for head and neck cancer with non-squamous cell histologies","volume":"96","author":"Akimoto","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib70","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00066-013-0489-9","article-title":"Particle therapy for mucosal melanoma of the head and neck: a single-institution retrospective comparison of proton and carbon ion therapy","volume":"190","author":"Demizu","year":"2014","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"10.1016\/j.coms.2021.11.008_bib71","doi-asserted-by":"crossref","first-page":"E293","DOI":"10.1016\/j.ijrobp.2015.07.1285","article-title":"Proton therapy for sinonasal mucosal melanoma","volume":"93","author":"Greenwalt","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib72","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1748-717X-9-162","article-title":"High-dose proton beam therapy for sinonasal mucosal malignant melanoma","volume":"9","author":"Fuji","year":"2014","journal-title":"Radiat Oncol"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib73","first-page":"385","article-title":"Mucosal melanoma of the head and neck: radiotherapy or surgery?","volume":"39","author":"Douglas","year":"2010","journal-title":"J\u00a0Otolaryngol Head Neck Surg"},{"issue":"768","key":"10.1016\/j.coms.2021.11.008_bib74","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1259\/0007-1285-64-768-1147","article-title":"Radical radiotherapy for 28 cases of mucosal melanoma in the nasal cavity and sinuses","volume":"64","author":"Gilligan","year":"1991","journal-title":"BJR"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib75","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/COC.0b013e31828d73bf","article-title":"Radiation therapy for mucosal melanoma of the head and neck","volume":"38","author":"Christopherson","year":"2015","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib76","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2015.10.025","article-title":"Phase II study of proton beam therapy as a nonsurgical approach for mucosal melanoma of the nasal cavity or para-nasal sinuses","volume":"118","author":"Zenda","year":"2016","journal-title":"Radiother Oncol"},{"issue":"16","key":"10.1016\/j.coms.2021.11.008_bib77","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1158\/1078-0432.CCR-13-0739","article-title":"Phase II randomized trial comparing high-dose IFN-\u03b12b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma","volume":"19","author":"Lian","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"19","key":"10.1016\/j.coms.2021.11.008_bib78","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.coms.2021.11.008_bib79","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma","volume":"378","author":"Eggermont","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.coms.2021.11.008_bib80","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib81","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0194599815606699","article-title":"Prognostic indicators for salvage surgery of recurrent sinonasal malignancy","volume":"154","author":"Kaplan","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.coms.2021.11.008_bib82","doi-asserted-by":"crossref","first-page":"S470","DOI":"10.1016\/j.ijrobp.2010.07.1102","article-title":"Fast neutron radiotherapy for locally recurrent and metastatic melanomas of the head and neck","volume":"78","author":"Ladra","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.coms.2021.11.008_bib83","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fonc.2019.00835","article-title":"Effect of radiotherapy combined with pembrolizumab on local tumor control in mucosal melanoma patients","volume":"9","author":"Kim","year":"2019","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib84","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1200\/JCO.2016.67.9258","article-title":"Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis","volume":"35","author":"D'Angelo","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.coms.2021.11.008_bib85","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1002\/cncr.30259","article-title":"The efficacy of anti-PD-1 agents in acral and mucosal melanoma: PD-1 in acral or mucosal melanoma","volume":"122","author":"Shoushtari","year":"2016","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.coms.2021.11.008_bib86","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00262-019-02351-7","article-title":"Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma","volume":"68","author":"Moya-Plana","year":"2019","journal-title":"Cancer Immunol Immunother"},{"issue":"32","key":"10.1016\/j.coms.2021.11.008_bib87","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1200\/JCO.19.00210","article-title":"Axitinib in combination with toripalimab, a humanized immunoglobulin G4 monoclonal antibody against programmed cell death-1, in patients with metastatic mucosal melanoma: an open-label phase IB trial","volume":"37","author":"Sheng","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib88","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJMoa1412690","article-title":"Improved overall survival in melanoma with combined dabrafenib and trametinib","volume":"372","author":"Robert","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.coms.2021.11.008_bib89","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1200\/JCO.2012.47.7836","article-title":"Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin","volume":"31","author":"Hodi","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.coms.2021.11.008_bib90","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/annonc\/mdx079","article-title":"Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial","volume":"28","author":"Guo","year":"2017","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11864-015-0330-z","article-title":"Treatment of NRAS-mutant melanoma","volume":"16","author":"Johnson","year":"2015","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"10.1016\/j.coms.2021.11.008_bib92","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(13)70024-X","article-title":"MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study","volume":"14","author":"Ascierto","year":"2013","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.coms.2021.11.008_bib93","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1200\/JCO.1999.17.9.2745","article-title":"Phase III multicenter randomized trial of the dartmouth regimen versus dacarbazine in patients with metastatic melanoma","volume":"17","author":"Chapman","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib94","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1200\/JCO.1994.12.4.806","article-title":"Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma","volume":"12","author":"Bajetta","year":"1994","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib95","first-page":"133","article-title":"Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: results of a multi-institutional Australian randomized trial","volume":"3","author":"Thomson","year":"1993","journal-title":"Melanoma Res"},{"issue":"6","key":"10.1016\/j.coms.2021.11.008_bib96","first-page":"458","article-title":"Prospective randomized comparison of dacarbazine (DTIC) versus DTIC plus interferon-alpha (IFN-alpha) in metastatic melanoma","volume":"13","author":"Young","year":"2001","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"10.1016\/j.coms.2021.11.008_bib97","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1200\/JCO.2012.42.1529","article-title":"Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanoma","volume":"31","author":"Flaherty","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib98","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1200\/JCO.2011.34.6270","article-title":"BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma","volume":"30","author":"Kim","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"15_suppl","key":"10.1016\/j.coms.2021.11.008_bib99","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.1200\/JCO.2019.37.15_suppl.9521","article-title":"A\u00a0randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced mucosal melanoma (NCT02023710)","volume":"37","author":"Yan","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.coms.2021.11.008_bib100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/CMR.0b013e32835efd8d","article-title":"Effect of paclitaxel\/carboplatin salvage chemotherapy in noncutaneous versus cutaneous metastatic melanoma","volume":"23","author":"Chang","year":"2013","journal-title":"Melanoma Res"},{"issue":"1","key":"10.1016\/j.coms.2021.11.008_bib101","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hed.23872","article-title":"Update on primary head and neck mucosal melanoma","volume":"38","author":"L\u00f3pez","year":"2016","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.coms.2021.11.008_bib102","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hed.10019","article-title":"Primary mucosal malignant melanoma of the head and neck","volume":"24","author":"Patel","year":"2002","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib103","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/archoto.2011.46","article-title":"Mucosal melanoma of the head and neck: predictors of prognosis","volume":"137","author":"Shuman","year":"2011","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.coms.2021.11.008_bib104","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3342\/ceo.2008.1.4.206","article-title":"Ki67 antigen as a predictive factor for prognosis of sinonasal mucosal melanoma","volume":"1","author":"Kim","year":"2008","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10.1016\/j.coms.2021.11.008_bib105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2020.07.017","article-title":"Head and neck mucosal melanoma: The United Kingdom national guidelines","volume":"138","author":"Nenclares","year":"2020","journal-title":"Eur J Cancer"}],"container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042369921001096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042369921001096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:14:10Z","timestamp":1760904850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042369921001096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1042369921001096"],"URL":"https:\/\/doi.org\/10.1016\/j.coms.2021.11.008","relation":{},"ISSN":["1042-3699"],"issn-type":[{"value":"1042-3699","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Head and Neck Mucosal Melanoma","name":"articletitle","label":"Article Title"},{"value":"Oral and Maxillofacial Surgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coms.2021.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}